Genomics-focused fund will support breakthroughs in life science research, clinical diagnostics, novel therapeutic platforms, and other health technologies.
Startups accelerating research into precision cancer therapies and advancing deep learning in healthcare are awarded for innovation.
By searching volumes of bacterial DNA, researchers have found several previously unknown genes that make bacteria resistant to last-resort antibiotics.
Researchers have examined MRI brain scans to identify children at high risk of developing MS before symptoms appear, which may lead to earlier diagnosis and treatment.
Genomics England partners with Inivata and Thermo Fisher Scientific to improve our understanding of cancer.
Expanded Potential Stem Cells have been created, that, for the first time, can produce all three types of blastocyst stem cells: embryo, placenta & yolk sac.
For the first time, scientists have documented a direct link between deletions in two genes, linked to multiple brain and body disorders.
New research into improving the genetic decoding of neurodevelopmental disorders promises to help future diagnosis of children with such conditions.
Cancer researchers have discovered a new class of fusion genes with properties that affect and may drive the development of cancer.
Researchers found that in the model organism E. coli, the fidelity of transcribing DNA comes at the expense of DNA repair.
Children of divorced parents are more likely to get divorced, and according to scientists, genetic factors are the primary explanation.
Two novel agents may have developed an alternative therapy for rare bone cancer, by stopping the growth and progress of Ewing Sarcoma.
Scientists have engineered a new way to deliver CRISPR technology inside cells by repairing the mutation that causes Duchenne muscular dystrophy.
The first gene therapy for cancer, approved by the FDA in August, will transform the treatment process, but it will bring both hope and challenges.
Rare benign tumours contain a diagram for regeneration of insulin-producing beta cells, which may hold the key to diabetes drug development.